News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Sapien 3 Valve Approved in Europe for Low-Risk Patients Michael O'Riordan November 06, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019
News Daily News PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction Michael O'Riordan April 29, 2019
News Daily News FDA Approves Orsiro Ultrathin-Strut Stent for CAD Michael O'Riordan February 22, 2019